BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28837569)

  • 21. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas.
    Rorive S; Lopez XM; Maris C; Trepant AL; Sauvage S; Sadeghi N; Roland I; Decaestecker C; Salmon I
    Mod Pathol; 2010 Oct; 23(10):1418-28. PubMed ID: 20693981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
    Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
    Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.
    Watanabe Y; Yamasaki F; Kajiwara Y; Saito T; Nishimoto T; Bartholomeusz C; Ueno NT; Sugiyama K; Kurisu K
    J Neurooncol; 2010 Dec; 100(3):449-57. PubMed ID: 20455002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
    PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening, identification of prostate cancer urinary biomarkers and verification of important spots.
    Zhao H; Zhao X; Lei T; Zhang M
    Invest New Drugs; 2019 Oct; 37(5):935-947. PubMed ID: 30610587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.
    Li L; Fang CJ; Ryan JC; Niemi EC; Lebrón JA; Björkman PJ; Arase H; Torti FM; Torti SV; Nakamura MC; Seaman WE
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3505-10. PubMed ID: 20133674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
    Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors.
    Liebrich M; Guo LH; Schluesener HJ; Schwab JM; Dietz K; Will BE; Meyermann R
    Arch Immunol Ther Exp (Warsz); 2007; 55(1):41-7. PubMed ID: 17221335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway.
    Wu T; Li Y; Liu B; Zhang S; Wu L; Zhu X; Chen Q
    PLoS One; 2016; 11(2):e0149361. PubMed ID: 26871431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
    Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R
    Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of FTL and FTH genes encoding ferretin subunits in lung and renal carcinomas].
    Kudriavtseva AV; Anedchenko EA; Oparina NIu; Krasnov GS; Kashkin KN; Dmitriev AA; Zborobskaia IB; Kondtrat'eva TT; Vinogradova TV; Zinov'eva MV; Kopantsev EP; Senchenko VN
    Mol Biol (Mosk); 2009; 43(6):1044-54. PubMed ID: 20088381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein.
    Naz N; Moriconi F; Ahmad S; Amanzada A; Khan S; Mihm S; Ramadori G; Malik IA
    Shock; 2013 Jun; 39(6):520-6. PubMed ID: 23524846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.
    Jézéquel P; Campion L; Spyratos F; Loussouarn D; Campone M; Guérin-Charbonnel C; Joalland MP; André J; Descotes F; Grenot C; Roy P; Carlioz A; Martin PM; Chassevent A; Jourdan ML; Ricolleau G
    Int J Cancer; 2012 Jul; 131(2):426-37. PubMed ID: 21898387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.